Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Impact of Parkinson's disease diagnosis validity on the association with cancer: A systematic review and meta-analysis (2025)
- Parkinsonism and Related Disorders
- Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms (2025)
- Annals of Neurology
- Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years (2025)
- Neurology
- Very Late-Onset Neurodegeneration with Brain Iron Accumulation Associated with Mild Chorea: A Clinicopathological Case (2025)
- Movement Disorders Clinical Practice
- Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease (2024)
- Annals of Neurology
- Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications (2024)
- Movement Disorders
- Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial (2024)
- JAMA Neurology
- Frontal white and gray matter abnormality in gambling disorder : A multimodal MRI study (2024)
- Journal of behavioral addictions
- In Silico Models for Evaluating Observed Associations Between Rest Tremor and Striatal Binding (2024)
- Movement Disorders
- Multimodal neuroimaging to characterize symptom-specific networks in movement disorders (2024)
- NPJ Parkinson's disease
- Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2 (2024)
- Case Reports in Neurological Medicine
- Parkinsonin taudin laiteavusteiset hoidot Varsinais-Suomessa ja Keski-Suomessa vuosina 2000-2022 (2024)
- Duodecim
- Rest Tremor in Parkinson's Disease Is Associated with Ipsilateral Striatal Dopamine Transporter Binding (2024)
- Movement Disorders
- Seasonal variation in D2/3 dopamine receptor availability in the human brain (2024)
- European Journal of Nuclear Medicine and Molecular Imaging
- Striatal Dopaminergic Function and Motor Slowing in Essential Tremor Plus (2024)
- Movement Disorders Clinical Practice
- Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study (2023)
- Journal of behavioral addictions
- A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene (2023)
- NPJ Parkinson's disease
- Budget-based classification of Parkinson's disease from resting state EEG (2023)
- IEEE Journal of Biomedical and Health Informatics
- Case-Fatality Rate in Parkinson's Disease: A Nationwide Registry Study (2023)
- Movement Disorders Clinical Practice
- Clinical spectrum and genotype-phenotype associations in Finnish patients with Wilson's disease (2023)
- Journal of the Neurological Sciences